EFFECTS OF ENALAPRIL ALONE, AND IN COMBINATION WITH HYDROCHLOROTHIAZIDE, ON RENIN-ANGIOTENSIN-ALDOSTERONE, RENAL-FUNCTION, SALT AND WATER-EXCRETION, AND BODY-FLUID COMPOSITION

被引:33
作者
BAUER, JH
GADDY, P
机构
[1] HARRY S TRUMAN MEM VET HOSP,MED SERV,COLUMBIA,MO 65201
[2] HARRY S TRUMAN MEM VET HOSP,NURSING SERV,COLUMBIA,MO 65201
关键词
D O I
10.1016/S0272-6386(85)80177-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:222 / 232
页数:11
相关论文
共 47 条
[1]   COMPARISON OF THE HORMONAL AND RENAL EFFECTS OF CAPTOPRIL IN SEVERE ESSENTIAL AND RENOVASCULAR HYPERTENSION [J].
ALDIGIER, JC ;
PLOUIN, PF ;
GUYENE, TT ;
THIBONNIER, M ;
CORVOL, P ;
MENARD, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (06) :1447-1452
[2]  
ANDREWS PM, 1983, FED PROC, V42, P3046
[3]   INTERRUPTION OF THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS BY CAPTOPRIL INDUCES SUSTAINED REDUCTION IN ALDOSTERONE SECRETION, POTASSIUM RETENTION AND NATRIURESIS [J].
ATLAS, SA ;
CASE, DB ;
SEALEY, JE ;
LARAGH, JH ;
MCKINSTRY, DN .
HYPERTENSION, 1979, 1 (03) :274-280
[4]   EFFECT OF POTASSIUM-CHLORIDE ON PLASMA-RENIN ACTIVITY AND PLASMA-ALDOSTERONE DURING SODIUM RESTRICTION IN NORMAL MAN [J].
BAUER, JH ;
GAUNTNER, WC .
KIDNEY INTERNATIONAL, 1979, 15 (03) :286-293
[5]   EFFECTS OF PROPRANOLOL THERAPY ON RENAL-FUNCTION AND BODY-FLUID COMPOSITION [J].
BAUER, JH .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (05) :927-931
[6]   RENAL-FUNCTION AND HEMODYNAMIC-STUDIES IN LOW-RENIN AND NORMAL-RENIN ESSENTIAL-HYPERTENSION [J].
BAUER, JH ;
BROOKS, CS ;
BURCH, RN .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (07) :1317-1323
[7]   BODY-FLUID COMPOSITION IN NORMAL AND HYPERTENSIVE MAN [J].
BAUER, JH ;
BROOKS, CS .
CLINICAL SCIENCE, 1982, 62 (01) :43-49
[8]  
BAUER JH, 1983, KIDNEY ESSENTIAL HYP, P193
[9]  
BAUER JH, 1983, KIDNEY ESSENTIAL HYP, P171
[10]   ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE [J].
BIOLLAZ, J ;
BRUNNER, HR ;
GAVRAS, I ;
WAEBER, B ;
GAVRAS, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :966-972